Literature DB >> 30499800

Textbook Outcomes Among Medicare Patients Undergoing Hepatopancreatic Surgery.

Katiuscha Merath1, Qinyu Chen1, Fabio Bagante1,2, Eliza Beal1, Ozgur Akgul1, Mary Dillhoff1, Jordan M Cloyd1, Timothy M Pawlik1.   

Abstract

OBJECTIVE: To define and test "Textbook Outcome" (TO)-a composite measure for healthcare quality-among Medicare patients undergoing hepatopancreatic resections. Hospital variation in TO and Medicare payments were analyzed.
BACKGROUND: Composite measures of quality may be superior to individual measures for the analysis of hospital performance.
METHODS: The Medicare Provider Analysis and Review (MEDPAR) Inpatient Files were reviewed to identify Medicare patients who underwent pancreatic and liver procedures between 2013 and 2015. TO was defined as: no postoperative surgical complications, no prolonged length of hospital stay, no readmission ≤ 90 days after discharge, and no postoperative mortality ≤ 90 days after surgery. Medicare payments were compared among patients who achieved TO versus patients who did not. Multivariable logistic regression was used to investigate patient factors associated with TO. A nomogram to predict probability of TO was developed and validated.
RESULTS: TO was achieved in 44% (n = 5919) of 13,467 patients undergoing hepatopancreatic surgery. Adjusted TO rates at the hospital level varied from 11.1% to 69.6% for pancreatic procedures and from 16.6% to 78.7% for liver procedures. Prolonged length of hospital stay represented the major obstacle to achieve TO. Average Medicare payments were substantially higher among patients who did not have a TO. Factors associated with TO on multivariable analysis were age, sex, Charlson comorbidity score, previous hospital admissions, procedure type, and surgical approach (all P > 0.05).
CONCLUSIONS: Less than one-half of Medicare patients achieved a TO following hepatopancreatic procedures with a wide variation in the rates of TO among hospitals. There was a discrepancy in Medicare payments for patients who achieved a TO versus patients who did not. TO could be useful for the public reporting of patient level hospital performance and hospital variation.

Entities:  

Mesh:

Year:  2020        PMID: 30499800     DOI: 10.1097/SLA.0000000000003105

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

1.  Impact of Metabolic Syndrome on Postoperative Outcomes Among Medicare Beneficiaries Undergoing Hepatectomy.

Authors:  Alessandro Paro; Diamantis I Tsilimigras; Djhenne Dalmacy; Rayyan S Mirdad; J Madison Hyer; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2021-02-05       Impact factor: 3.452

2.  ASO Author Reflections: Chance of Textbook Outcome following Hepatopancreatic Surgery Varies Based on Cancer Center Designation.

Authors:  Rittal Mehta; Diamantis I Tsilimigras; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2020-03-25       Impact factor: 5.344

3.  Dedicated Cancer Centers are More Likely to Achieve a Textbook Outcome Following Hepatopancreatic Surgery.

Authors:  Rittal Mehta; Diamantis I Tsilimigras; Anghela Z Paredes; Kota Sahara; Mary Dillhoff; Jordan M Cloyd; Aslam Ejaz; Susan White; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2020-02-27       Impact factor: 5.344

Review 4.  Quality Versus Costs Related to Gastrointestinal Surgery: Disentangling the Value Proposition.

Authors:  Rohan Shah; Adrian Diaz; Marzia Tripepi; Fabio Bagante; Diamantis I Tsilimigras; Nikolaos Machairas; Fragiska Sigala; Dimitrios Moris; Savio George Barreto; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2020-07-23       Impact factor: 3.452

5.  Association of Depression with In-Patient and Post-Discharge Disposition and Expenditures Among Medicare Beneficiaries Undergoing Resection for Cancer.

Authors:  Alessandro Paro; J Madison Hyer; Timothy Pawlik
Journal:  Ann Surg Oncol       Date:  2021-03-21       Impact factor: 5.344

6.  Impact of Residential Racial Integration on Postoperative Outcomes Among Medicare Beneficiaries Undergoing Resection for Cancer.

Authors:  Alessandro Paro; Djhenne Dalmacy; J Madison Hyer; Diamantis I Tsilimigras; Adrian Diaz; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2021-04-24       Impact factor: 5.344

7.  Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study.

Authors:  Sivesh K Kamarajah; Samer A Naffouje; George I Salti; Fadi S Dahdaleh
Journal:  Ann Surg Oncol       Date:  2021-01-04       Impact factor: 5.344

8.  Critical evaluation of quality of hepatopancreatic surgery in a medium-volume center in Finland using the Accordion Severity Grading System and the Postoperative Morbidity Index.

Authors:  Kyösti Tahkola; Ville Väyrynen; Ilmo Kellokumpu; Olli Helminen
Journal:  J Gastrointest Oncol       Date:  2020-08

9.  A National Assessment of Optimal Oncologic Surgery for Distal Pancreatic Adenocarcinomas.

Authors:  Katherine Hrebinko; Samer Tohme; Richard S Hoehn; Samer AlMasri; Sidrah Khan; Christof Kaltenmeier; Kenneth K Lee; Alessandro Paniccia; Amer Zureikat; Ibrahim Nassour
Journal:  Pancreas       Date:  2021-03-01       Impact factor: 3.327

10.  Impact of Perioperative Thromboembolic Complications on Future Long-term Risk of Venous Thromboembolism among Medicare Beneficiaries Undergoing Complex Gastrointestinal Surgery.

Authors:  Alessandro Paro; Djhenne Dalmacy; J Madison Hyer; Diamantis I Tsilimigras; Adrian Diaz; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2021-07-19       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.